Cryopreservation of Animal Cells: Principles and Protocols
By Dr. Zubair Khalid, DVM, MS, PhD ·

Introduction to Cryopreservation of Animal Cells
Cryopreservation is the process of preserving living cells, tissues, or other biological materials by cooling them to ultra-low temperatures, typically −196°C (the boiling point of liquid nitrogen) or −80°C for short-term storage. At these temperatures, all metabolic activity ceases because the kinetic energy of molecules is insufficient to drive biochemical reactions. The goal of cryopreservation of animal cells is to create a stable, reproducible cell bank that can be thawed months or years later with high viability and functional integrity.
Why Cryopreserve Cells?
Cryopreservation serves several essential functions in both research and biotechnology. First, it protects against genetic drift. Continuous culture of immortalized cell lines selects for cells that grow rapidly under specific culture conditions, gradually altering the population's genotype and phenotype. Freezing early-passage cells creates a reference stock that maintains the original characteristics of the line. Second, cryopreservation prevents contamination and loss. A contaminated or senescent culture can be discarded and replaced from frozen stock rather than requiring re-derivation. Third, cryopreservation enables the transport of cells between laboratories without the logistical burden of maintaining live cultures. Finally, it is indispensable for the long-term storage of primary cells, stem cells, and genetically modified lines, including those used in CRISPR in T Cells research and other gene-editing applications where a validated clone must be preserved.
The Challenge of Ice Formation
The fundamental obstacle in cryopreservation is that water, which constitutes 70–85% of a cell's mass, forms ice when cooled below its freezing point. Ice crystals can mechanically disrupt cellular membranes and organelles. Moreover, as water leaves the intracellular space to form extracellular ice, cells experience severe osmotic shrinkage. The challenge is to navigate the physical chemistry of ice formation in a way that minimizes damage. This requires understanding the cryobiology of water, the role of cryoprotective agents, and the kinetics of cooling and warming.
Principles of Cryobiology
Cryobiology is the study of the effects of low temperatures on biological systems. The behavior of water during freezing is governed by thermodynamics and kinetics, and the damage inflicted on cells is largely a consequence of two interrelated phenomena: ice crystal formation and osmotic/solution effects.
Ice Crystal Formation and Cell Damage
When an aqueous solution is cooled below its freezing point, ice nucleation occurs either homogeneously (spontaneously, requiring temperatures below approximately −40°C) or heterogeneously (catalyzed by impurities, container walls, or cellular structures). In a typical cell suspension, ice forms first in the extracellular medium because the intracellular fluid has a higher solute concentration and therefore a lower freezing point.
Intracellular ice formation is generally lethal. Ice crystals that form inside the cell can puncture the plasma membrane, disrupt organelles, and damage the cytoskeleton. The probability of intracellular ice formation depends on the cooling rate. If cooling is too rapid, water does not have time to leave the cell before the intracellular fluid reaches its freezing point, leading to the formation of small, damaging ice crystals within the cytoplasm. If cooling is too slow, cells are exposed to prolonged hyperosmotic stress, which we discuss below. The optimal cooling rate is therefore a compromise between these two extremes.
Osmotic Effects and Solution Effects
As extracellular ice forms, pure water is sequestered into the ice lattice, leaving the remaining extracellular fluid increasingly concentrated with solutes such as sodium chloride, potassium chloride, and proteins. This creates an osmotic gradient across the plasma membrane. Water leaves the cell to equilibrate with the hypertonic extracellular environment, causing the cell to shrink. This is the basis of the "solution effects" injury described by Peter Mazur in the 1960s.
The damage from solution effects is multifactorial. Severe dehydration can cause the plasma membrane to reach a minimum critical volume, beyond which it cannot shrink without irreversible damage. High concentrations of intracellular solutes can denature proteins and destabilize lipid bilayers. Prolonged exposure to hypertonic conditions—even at temperatures above freezing—can trigger apoptosis or necrosis. The time of exposure to these concentrated solutions is a function of the cooling rate: slower cooling means longer exposure to damaging solute concentrations.
The relationship between cooling rate and cell survival is classically described by a bell-shaped curve. For most mammalian cells, the optimal cooling rate is between 1°C and 3°C per minute. At rates below this, solution effects dominate; at rates above this, intracellular ice formation dominates. The precise optimum depends on cell type, membrane permeability to water, and the type and concentration of cryoprotectant used.
Cryoprotectants: Types and Mechanisms
Cryoprotectants are compounds added to cell suspensions before freezing to reduce ice-related damage. They fall into two broad categories: penetrating (or permeating) cryoprotectants, which cross the plasma membrane, and non-penetrating cryoprotectants, which remain extracellular.
Dimethyl Sulfoxide (DMSO)
Dimethyl sulfoxide (DMSO) is the most widely used penetrating cryoprotectant for animal cells. It is a small, polar, aprotic molecule (molecular weight 78.13 g/mol) that readily crosses biological membranes. DMSO works through several mechanisms. It colligatively lowers the freezing point of the solution, reducing the amount of ice formed at any given temperature. It also interacts with water molecules, disrupting hydrogen bonding and preventing the formation of large, damaging ice crystals. Additionally, DMSO partitions into lipid bilayers, where it modulates membrane fluidity and protects against phase transitions that occur at low temperatures.
The typical working concentration of DMSO is 5–10% (v/v) in complete culture medium containing 10–20% fetal bovine serum (FBS). Serum proteins provide additional protection by stabilizing membranes and scavenging free radicals. DMSO is toxic to cells at room temperature, particularly over extended exposure times. Therefore, the time between adding DMSO to the cell suspension and initiating the freezing process should be minimized—ideally less than 30 minutes. This toxicity is discussed further in the troubleshooting section.
Glycerol and Other Penetrating Agents
Glycerol is another penetrating cryoprotectant, historically used for red blood cells and spermatozoa. It is less toxic than DMSO at equivalent concentrations but is a weaker cryoprotectant for most cultured cell lines. Glycerol is used at concentrations of 10–20% (v/v) and requires longer equilibration times because it permeates membranes more slowly than DMSO. Other penetrating cryoprotectants include ethylene glycol, propylene glycol (1,2-propanediol), and formamide. These are used primarily in specialized applications such as oocyte and embryo cryopreservation, where DMSO toxicity is a greater concern.
Non-Penetrating Cryoprotectants (e.g., Sucrose, Trehalose)
Non-penetrating cryoprotectants remain in the extracellular space and exert their protective effects without entering the cell. Common examples include sucrose, trehalose, glucose, mannitol, and polyvinylpyrrolidone (PVP). These compounds act by increasing extracellular osmolarity, which promotes controlled cellular dehydration before and during freezing. This reduces the amount of water available to form intracellular ice. They also stabilize the plasma membrane by interacting with phospholipid head groups.
Trehalose, a non-reducing disaccharide, is particularly effective and is found naturally in organisms that survive desiccation and freezing, such as tardigrades and certain nematodes. Trehalose is often used in combination with a penetrating cryoprotectant, such as DMSO, to achieve synergistic protection. Non-penetrating cryoprotectants are especially valuable in protocols where DMSO toxicity must be minimized, such as in the cryopreservation of stem cells for clinical applications.
Cooling Rates and Freezing Methods
The method by which cells are cooled from room temperature to the storage temperature is a critical determinant of post-thaw viability. The goal is to traverse the "danger zone" of −15°C to −60°C, where ice nucleation and solution effects are most damaging, at a rate that balances the two injury mechanisms.
Slow Freezing vs. Vitrification
Slow freezing, also called controlled-rate freezing, involves cooling cells at a defined rate, typically 1°C to 3°C per minute, to approximately −80°C before transferring them to liquid nitrogen. During slow freezing, extracellular ice forms, and cells dehydrate progressively. This approach is suitable for most adherent and suspension cell lines.
Vitrification, by contrast, is an ultra-rapid freezing method that uses high concentrations of cryoprotectants (often 40–60% total solute) to prevent ice formation altogether. The solution becomes a glass-like, amorphous solid upon cooling. Vitrification is used for oocytes, embryos, and some stem cell applications where ice crystal damage is particularly detrimental. The advantages of vitrification are the absence of ice crystal formation and reduced osmotic stress. The disadvantages include the high toxicity of the concentrated cryoprotectant solutions and the technical difficulty of achieving sufficiently rapid cooling rates.
Controlled-Rate Freezers
Controlled-rate freezers are programmable devices that precisely regulate the cooling rate by injecting liquid nitrogen or cold nitrogen gas into a chamber while monitoring the sample temperature with a thermocouple. They allow the user to define multi-step cooling profiles, such as cooling at 1°C/min to −40°C, then at 10°C/min to −80°C. This is the gold standard for cryopreserving cells where maximum viability is required, such as primary cells, stem cells, and cells intended for clinical use. Controlled-rate freezers also allow the release of latent heat of fusion—the heat released when water crystallizes—which can otherwise cause a transient warming of the sample.
Mr. Frosty and Other Passive Devices
For routine laboratory use, passive cooling devices are a practical and cost-effective alternative. The most common is the "Mr. Frosty" container (Nalgene), which is a sealed polycarbonate chamber containing isopropanol. When placed in a −80°C freezer, the isopropanol cools at a rate of approximately −1°C per minute, providing a near-optimal cooling rate for many cell types. The container must be used with fresh isopropanol and pre-chilled to 4°C before use. Other passive devices include polystyrene foam boxes and specialized freezing containers that use a defined thermal mass to achieve a reproducible cooling rate.
It is important to note that passive devices do not provide the same precision as controlled-rate freezers. The cooling rate can vary with the number of vials, the volume of the cryoprotectant solution, and the efficiency of the −80°C freezer. Nevertheless, for established cell lines, passive cooling is usually sufficient to achieve acceptable viability. For detailed guidance on executing these procedures, see Freeze Cells for Cryopreservation.
Thawing and Recovery
The thawing process is as important as the freezing process. A rapid thaw is generally recommended because it minimizes the time cells spend in the presence of high concentrations of cryoprotectant and prevents the recrystallization of ice—a phenomenon where small ice crystals formed during freezing grow into larger, more damaging crystals during slow warming.
Rapid Thawing Protocol
The standard protocol for thawing a 1 mL cryovial is as follows:
- Remove the vial from liquid nitrogen storage using forceps or a cryoglove. Do not touch the vial with bare hands.
- Loosen the cap one-quarter turn to release any residual liquid nitrogen that may have entered the vial, then retighten.
- Place the vial in a 37°C water bath, ensuring that the entire vial is submerged but the cap and neck remain above the water line to prevent contamination.
- Swirl the vial gently for 1–2 minutes until only a small ice crystal remains.
- Remove the vial from the water bath and wipe it with 70% ethanol before transferring it to a biosafety cabinet.
The goal is to thaw the cells as quickly as possible—ideally within 60–90 seconds—to avoid osmotic stress and DMSO toxicity.
Dilution and Washing
Once thawed, the cells are immediately diluted into pre-warmed culture medium. The cryoprotectant must be removed because DMSO is toxic at 37°C and can interfere with cell attachment and proliferation. The dilution should be performed slowly and gently to avoid osmotic shock. A typical procedure is:
- Transfer the thawed cell suspension dropwise into a 15 mL conical tube containing 9–10 mL of pre-warmed complete medium.
- Mix gently by inversion or slow pipetting.
- Centrifuge at 200–300 × g for 5 minutes at room temperature.
- Aspirate the supernatant, being careful not to disturb the cell pellet.
- Resuspend the pellet in fresh complete medium and transfer to a culture vessel.
For cells that are particularly sensitive to centrifugation, such as primary neurons or some stem cells, an alternative is to dilute the thawed suspension directly into a large volume of medium, allow the cells to attach overnight, and then replace the medium the next day. This avoids the stress of centrifugation but exposes cells to DMSO for a longer period.
Viability Assays (Trypan Blue, etc.)
Post-thaw viability should be assessed to confirm that the cryopreservation process was successful. The most common method is the trypan blue exclusion assay. Trypan blue is a diazo dye that is impermeable to intact cell membranes. Viable cells exclude the dye and appear bright under a light microscope, while dead cells take up the dye and appear blue. The procedure is:
- Mix 10 µL of cell suspension with 10 µL of 0.4% trypan blue solution.
- Load 10 µL onto a hemocytometer or automated cell counter.
- Count the number of viable (unstained) and non-viable (blue) cells.
- Calculate viability as: (viable cells / total cells) × 100%.
A viability of greater than 70% is generally acceptable for established cell lines, while primary cells and stem cells may require higher thresholds. Other viability assays include fluorescein diacetate/propidium iodide staining, which distinguishes live and dead cells by enzymatic activity and membrane integrity, and the MTT or alamarBlue assays, which measure metabolic activity. For cells intended for downstream functional studies, such as CRISPR Delivered to Cells experiments, it is also advisable to assess post-thaw proliferation and function, not just membrane integrity.
Cell-Specific Considerations
Not all cells cryopreserve equally. The optimal protocol depends on the cell type, its origin, and its intended use. A "one-size-fits-all" approach will yield suboptimal results for many cell types.
Adherent vs. Suspension Cells
Adherent cells, such as fibroblasts, epithelial cells, and endothelial cells, are typically cryopreserved as a single-cell suspension. They must be detached from the culture surface using trypsin-EDTA or another dissociation reagent, neutralized with serum-containing medium, and counted before freezing. It is critical that adherent cells are in the logarithmic growth phase (70–80% confluent) at the time of freezing; overconfluent cultures have reduced viability after thawing.
Suspension cells, such as lymphocytes, hybridomas, and many hematopoietic lines, are simpler to prepare because they are already in suspension. They are collected by centrifugation, resuspended in freezing medium, and aliquoted into cryovials. Suspension cells generally tolerate cryopreservation well, provided they are healthy and in mid-log phase.
Stem Cells and Primary Cells
Stem cells, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs), are more sensitive to cryopreservation than immortalized lines. They require careful optimization of the freezing medium, cooling rate, and thawing procedure. For ESCs and iPSCs, a common approach is to use a defined, serum-free freezing medium containing 10% DMSO and a ROCK inhibitor (e.g., Y-27632 at 10 µM) to prevent apoptosis upon thawing. Cells are often frozen as small clumps rather than single cells, as single-cell dissociation triggers anoikis in many pluripotent stem cell lines.
Primary cells, which are freshly isolated from tissues, are generally more fragile than established lines. They have a finite lifespan in culture and cannot be replaced if lost. Primary cells should be frozen at the earliest possible passage, in high-density suspensions, and with a higher concentration of serum (20–30%) in the freezing medium. Some primary cells, such as hepatocytes, are particularly sensitive to cold and require specialized protocols, including the use of proprietary freezing media.
Insect and Fish Cell Lines
Insect cell lines, such as Sf9 and Sf21 (derived from Spodoptera frugiperda), are widely used for baculovirus-based protein expression. They are typically frozen at a density of 1–2 × 10⁷ cells/mL in medium containing 10% DMSO and 10–20% FBS. The optimal cooling rate for insect cells is often slightly slower than for mammalian cells, around 1°C per minute. Fish cell lines, such as RTG-2 (rainbow trout gonad), are cold-adapted and may require different cryoprotectant concentrations or cooling rates. For fish cells, glycerol is sometimes preferred over DMSO because it is less toxic at the lower culture temperatures used for these cells.
Common Pitfalls and Troubleshooting
Even with careful attention to protocol, cryopreservation can fail. The following are the most common mistakes and how to avoid them.
DMSO Toxicity at Room Temperature
DMSO is toxic to cells at temperatures above 4°C. The toxicity is time- and concentration-dependent. Leaving cells in DMSO-containing freezing medium at room temperature for extended periods—for example, while counting cells or labeling tubes—can significantly reduce viability. To minimize toxicity, pre-chill the freezing medium to 4°C, add it to the cells immediately before aliquoting, and transfer the vials to the cooling device or freezer within 15–30 minutes. Use Cryopreservation Labels for Cells that are resistant to low temperatures and alcohol to avoid label failure during storage.
Inconsistent Cooling Rates
Inconsistent cooling rates are a frequent cause of poor viability. This can occur when using a passive cooling device that has not been properly equilibrated, when the isopropanol in a Mr. Frosty container has been used too many times (it should be replaced after 5 uses), or when vials are placed in a −80°C freezer without any insulation, resulting in cooling rates of 10°C/min or more. Another common error is transferring vials to liquid nitrogen before they have reached −80°C, which can cause a rapid temperature drop and intracellular ice formation. Always ensure that vials have been at −80°C for at least 4 hours or overnight before transfer to liquid nitrogen.
Contamination Risks
Contamination can occur at several points in the cryopreservation workflow. The water bath used for thawing is a common source of bacterial and fungal contamination. Always use a clean water bath, and wipe the vial with 70% ethanol before opening. Liquid nitrogen storage tanks can also harbor contaminants, including viruses and mold spores. To minimize this risk, use the vapor phase of liquid nitrogen for storage rather than the liquid phase, and use screw-cap cryovials with an internal O-ring seal. Additionally, always wear appropriate personal protective equipment, including a face shield and cryogloves, when handling liquid nitrogen, as vials can explode if liquid nitrogen has entered them and rapidly vaporizes upon warming.
Practical Summary and Best Practices
The following is a consolidated protocol for the cryopreservation of a typical adherent mammalian cell line. This protocol assumes the use of a passive cooling device.
Step-by-Step Protocol
- Prepare freezing medium: Complete culture medium supplemented with 10% (v/v) DMSO and 20% (v/v) FBS. Prepare fresh and chill to 4°C.
- Harvest cells: Aspirate the culture medium from a 70–80% confluent flask. Wash the monolayer with phosphate-buffered saline (PBS) without Ca²⁺/Mg²⁺. Add trypsin-EDTA (0.25% trypsin, 0.02% EDTA) and incubate at 37°C for 2–5 minutes until cells detach.
- Neutralize and count: Add complete medium containing serum to neutralize the trypsin. Transfer the cell suspension to a conical tube and count the cells using a hemocytometer.
- Centrifuge: Centrifuge at 200 × g for 5 minutes. Aspirate the supernatant.
- Resuspend in freezing medium: Resuspend the cell pellet in pre-chilled freezing medium at a density of 1–5 × 10⁶ cells/mL. Work quickly to minimize DMSO exposure.
- Aliquot: Dispense 1 mL of the cell suspension into each labeled cryovial. Use cryovials with external threads and an O-ring seal.
- Cool: Place the cryovials in a Mr. Frosty container pre-chilled to 4°C. Place the container in a −80°C freezer for at least 4 hours or overnight.
- Transfer to liquid nitrogen: Move the vials to a liquid nitrogen storage tank (vapor phase preferred) for long-term storage. Record the location in a cell bank log.
Quality Control and Record Keeping
A robust cryopreservation program requires meticulous record keeping. Each vial should be labeled with the cell line name, passage number, date of freezing, the type of freezing medium, and the operator's initials. A separate log should track the location of each vial in the liquid nitrogen tank, the number of vials in the bank, and the results of post-thaw viability tests. It is also good practice to thaw one vial from each new batch 24–48 hours after freezing to confirm viability before committing the batch to long-term storage. This is particularly important when establishing a master cell bank for Animal Cell Culture workflows or for cells used in the production of Transgenic Animal models, where a validated, contamination-free cell stock is essential.
Frequently Asked Questions
What is the purpose of cryopreservation of animal cells?
The purpose is to preserve cells in a state of suspended animation at ultra-low temperatures, typically −196°C in liquid nitrogen, where all metabolic activity ceases. This allows for long-term storage of cell lines, protection against genetic drift and contamination, transport of cells between laboratories, and the maintenance of valuable primary cells and genetically modified lines.
Why is DMSO used in cryopreservation?
DMSO is a penetrating cryoprotectant that crosses the plasma membrane and protects cells from freezing damage. It lowers the freezing point of the solution, reduces ice crystal formation, and stabilizes cellular membranes. It is used at concentrations of 5–10% (v/v) and is effective for most animal cell types.
What is the optimal cooling rate for most animal cells?
The optimal cooling rate for most mammalian cells is between 1°C and 3°C per minute. This rate balances two competing injury mechanisms: solution effects (damage from hyperosmotic stress at slow cooling rates) and intracellular ice formation (damage from ice crystals at fast cooling rates).
How do you thaw frozen cells correctly?
Thaw cells rapidly by placing the cryovial in a 37°C water bath for 1–2 minutes, until only a small ice crystal remains. Wipe the vial with 70% ethanol, then transfer the cells dropwise into pre-warmed culture medium. Centrifuge, remove the DMSO-containing supernatant, and resuspend the cells in fresh medium.
What happens if cells are frozen without cryoprotectant?
Without a cryoprotectant, cells suffer severe damage from both ice crystal formation and solution effects. Extracellular ice formation causes extreme hyperosmotic stress, leading to excessive cell shrinkage and membrane damage. Intracellular ice formation, which is likely at any cooling rate without a cryoprotectant, is almost invariably lethal.
Can all animal cells be frozen using the same protocol?
No. Different cell types have different optimal cooling rates, cryoprotectant concentrations, and freezing media. Stem cells, primary cells, insect cells, and fish cells may require specialized protocols. Adherent and suspension cells also differ in how they are prepared for freezing.
How long can cells be stored in liquid nitrogen?
Cells stored in liquid nitrogen at −196°C can theoretically be maintained indefinitely, as all biochemical activity ceases at this temperature. In practice, viability can decline over decades due to background radiation damage, but cells stored for 10–30 years have been successfully recovered. Storage at −80°C is only suitable for short-term storage (weeks to months) because ice crystal growth and enzymatic activity are not fully arrested at this temperature.
Key Takeaways
- Cryopreservation of animal cells relies on the use of penetrating cryoprotectants like DMSO and non-penetrating agents like trehalose to prevent ice crystal formation and osmotic damage.
- The optimal cooling rate for most mammalian cells is 1–3°C per minute, achieved using controlled-rate freezers or passive devices like Mr. Frosty.
- Rapid thawing in a 37°C water bath and immediate removal of DMSO by centrifugation are essential for high post-thaw viability.
- Different cell types—adherent, suspension, primary, stem, insect, and fish—require tailored cryopreservation protocols.
- Common failures include DMSO toxicity at room temperature, inconsistent cooling rates, and contamination from water baths or liquid nitrogen storage.
- Proper labeling, record keeping, and post-thaw viability testing are critical for maintaining a reliable cell bank.
- Cells stored in liquid nitrogen can be preserved for decades, making cryopreservation an indispensable tool in cell biology, biotechnology, and regenerative medicine.
Further Reading
- Mohammed L, Marquez-Curtis LA, Elliott JAW. Cryopreservation of human cerebral microvascular endothelial cells with glycerol. Cryobiology. 2023. PubMed 37328025
- Wang J, Li R. Effects, methods and limits of the cryopreservation on mesenchymal stem cells. Stem cell research & therapy. 2024. PubMed 39343920
- Hoffman RM et al. Cryopreservation of Hair-Follicle Associated Pluripotent (HAP) Stem Cells Maintains Differentiation and Hair-Growth Potential. Advances in experimental medicine and biology. 2016. PubMed 27837565
- Hubel A. Parameters of cell freezing: implications for the cryopreservation of stem cells. Transfusion medicine reviews. 1997. PubMed 9243775
- Sun JD et al. Cryopreservation of porcine skin-derived stem cells using melatonin or trehalose maintains their ability to self-renew and differentiate. Cryobiology. 2022. PubMed 35716769
- Morris CB. Cryopreservation of animal and human cell lines. Methods in molecular biology (Clifton, N.J.). 2007. PubMed 18080474